Virtual Clinical Trials Market

Virtual clinical trials is a relatively new method of conducting clinical research using technologies and online social engagement platforms. Virtual trials have the potential to drive significant digital alterations in the clinical research methodologies to create an improved patient-centric ecosystem. Virtual clinical trials are digitally empowered the clinical trial process.

Market Dynamics:

Growing burden of diseases, spike in virtual clinical trials adoption, rise in adoption of telehealth, rise in adoption of novel technologies, rise in healthcare digitization, technological advancements, and the outbreak of COVID-19 (pandemic) are major factors expected to boost the growth of the global virtual clinical trials market during the forecast period.

For instance, in November 2019, Johnson & Johnson in collaboration with PRA Health Sciences, launched the clinical trial set-up CHIEF-HF, a completely decentralize, indication-seeking, mobile clinical study. The company aims to utilize wearable devices and smart technology to efficiently gather and analyze evidence for assessing effectiveness of Canagliflozin in the populace with heart failure with presence of absence of type 2 diabetes.

Key features of the study:

• This report provides in-depth analysis of the global virtual clinical trials market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global virtual clinical trials market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Delve Health, Clario, Clinical Ink, Castor, Accenture, Thread, Science 37, Medable, Dassault Systèmes, and eElinicalHealth (CLINPAL), among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global virtual clinical trials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global virtual clinical trials market.

Detailed Segmentation:

• Global Virtual Clinical Trials Market, By Study Type:
  • Interventional
  • Others
• Global Virtual Clinical Trials Market, By Phases:
  • Late Stage
  • Early Stage
• Global Virtual Clinical Trials Market, By Company Size:
  • Small- & Mid-sized
  • Large-sized
• Global Virtual Clinical Trials Market, By Therapeutic Area:
  • Oncology
  • Rare & Genetic Diseases
  • CNS
  • Immunology
  • Others
• Global Virtual Clinical Trials Market, By Geography:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Company Profiles:
  • Delve Health
  • Clario
  • Clinical Ink
  • Castor
  • Accenture
  • Thread
  • Science 37
  • Medable
  • Dassault Systèmes
  • eElinicalHealth (CLINPAL)